• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Pediapharm Announces Extension of Debentures and Warrants

    Gabrielle Lakusta
    Jan. 31, 2018 08:46AM PST
    Pharmaceutical Investing

    Pediapharm (TSXV:PDP) has proposed to amend its existing convertible secured debentures and common share purchase warrants issued on March 30, 2015 with a maturity date of March 30, 2019. As quoted in the press release: The Company expects to enter into agreements with all of the Holders, representing an aggregate of $5,500,000 of Debentures. Any …

    Pediapharm (TSXV:PDP) has proposed to amend its existing convertible secured debentures and common share purchase warrants issued on March 30, 2015 with a maturity date of March 30, 2019.
    As quoted in the press release:

    The Company expects to enter into agreements with all of the Holders, representing an aggregate of $5,500,000 of Debentures. Any such extensions that are not approved by the individual Holders will remain subject to the original terms of the Debentures and shall mature on the Original Maturity Date.

    Click here to read the full press release.

    pharmaceutical investing
    The Conversation (0)

    Go Deeper

    AI Powered
    InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

    InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update

    GreenPower Announces Closing of the First Tranche of Private Placement of Convertible Debentures

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    Ă—